Interleukin-18 promotes the antitumor ability of natural killer cells in colorectal cancer via the miR-574-3p/TGF-beta 1 axis

Li, YP; Du, XR; Zhang, R; Yang, Q

Li, YP; Yang, Q (corresponding author), Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Gastroenterol,Longhua Branch, 101 Longguan East Rd, Shenzhen 518020, Guangdong, Peoples R China.; Li, YP; Yang, Q (corresponding author), Southern Univ Sci & Technol, Affiliated Hosp 1, 101 Longguan East Rd, Shenzhen 518020, Guangdong, Peoples R China.

BIOENGINEERED, 2021; 12 (1): 763

Abstract

Interleukin (IL)-18 has a clear antitumor effect; however, its mechanisms of action are not understood in patients with colorectal cancer (CRC). Here,......

Full Text Link